Hepatocyte-derived exosomal miR-27a activates hepatic stellate cells through the inhibition of PINK1-mediated mitophagy in MAFLD
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The role of exosome-mediated mitophagy in the crosstalk between hepatocytes (HCs) and hepatic stellate cells (HSCs) in metabolic-associated fatty liver disease (MAFLD) remains unknown. Serum exosomal miR-27a levels were markedly increased and positively correlated with liver fibrosis in MAFLD patients and mice. Exosomal miR-27a was released from lipotoxic HCs and specifically transmitted to recipient-activated HSCs. PINK1, the key target of miR-27a, primarily mediates mitophagy. Overexpression of miR-27a or knockdown of PINK1 or lipotoxic HC-exosomal miR-27a impaired mitochondria (inhibiting mitophagy, respiration, membrane potential, and transcription while promoting reactive oxygen species production) in activated HSCs and stimulated HSC-derived fibroblasts (promoting activation and proliferation while inhibiting autophagy). High exosomal miR-27a serum levels and a lack of hepatic PINK1-mediated mitophagy were directly related to liver fibrosis in MAFLD mice. Lipotoxic HC exosome transplantation aggravated the degree of PINK1-mediated mitophagy suppression, steatohepatitis, lipidosis, and fibrosis in the livers of MAFLD mice with cirrhosis. Both in vitro and in vivo , exosomes derived from miR-27a-knockdown HCs could not facilitate the abovementioned deteriorating effects. In conclusion, lipotoxic HC-exosomal miR-27a plays a pivotal role in inhibiting mitophagy and in promoting MAFLD-related liver fibrosis by negatively regulating PINK1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 1×
“Advanced liver fibrosis (ALF) (fibrotic stage SR 3) was identified as the major prognostic factor for MAFLD, and the fibrosis stage was independently associated with long-term overall mortality.(1,2)”
BackgroundYing, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J. B., Ofrecio, J. M., Wollam, J., Hernandez-Carretero, A., Fu, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.035 · Cited by 1,191 · cited 2×
“The majority of extracellular microRNAs (miRNAs) are secreted via exosomes.(7) Hepatocytes (HCs) injured by lipotoxic fatty acids were found to produce exosomes enriched in miR-17 and miR-92 clusters, which were taken up by hepatic stellate cells (HSCs), ultimately leading to fibrogenic activation.”
BackgroundPINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278 · cited 1×
“DISCUSSION MAFLD encompasses a spectrum of liver disorders that range from benign steatosis to steatohepatitis (NASH) or even cirrhosis.(13) The incidence of NASH-related cirrhosis is rapidly increasing, as is the need for liver transplantation.”
BackgroundLee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03389-2 · Cited by 233 · cited 1×
“Increase and change in exosome contents were found in HCs due to lipid accumulation.(17) Exploring the key exosomal miRNAs is meaningful to understanding MAFLD-related fibrosis.”
BackgroundPovero, D., Panera, N., Eguchi, A., Johnson, C. D., Papouchado, B. G., de Araujo Horcel, L., Pinatel, E. M., Alisi, A., Nobili, V., & Feldstein, A. E. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.07.007 · Cited by 221
Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 172 · cited 3×
“regulate PINK1 in HSCs miR27a is known to participate in the pathogenesis of Parkinson’s disease by impairing mitochondrial functions through targeting of PINK1.(9) PINK1 has also been reported as an important regulator of MAFLDand liverfibrosis.”
BackgroundZhang, X.-W., Zhou, J.-C., Peng, D., Hua, F., Li, K., Yu, J.-J., Lv, X.-X., Cui, B., Liu, S.-S., Yu, J.-M., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1635383 · Cited by 166
Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis
Kobayashi, K., Araya, J., Minagawa, S., Hara, H., Saito, N., Kadota, T., Sato, N., Yoshida, M., Tsubouchi, K., Kurita, Y., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600265 · Cited by 145
Li, S., Lin, Q., Shao, X., Zhu, X., Wu, J., Wu, B., Zhang, M., Zhou, W., Zhou, Y., Jin, H., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.005 · Cited by 112
Self-citation
Cited by
Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities
Pei, Q., Yi, Q., & Tang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119671 · Cited by 121
“Lipotoxic hepatocyte-derived exosomal miR-27a was found to promote the development of liver fibrosis in metabolically associated fatty liver disease (MAFLD) by enhancing HSC proliferation and activation and inhibiting aHSC autophagy [40].”
BackgroundSinusoidal communication in chronic liver disease
Gibert-Ramos, A., Andrés-Rozas, M., Pastó, R., Alfaro-Retamero, P., Guixé-Muntet, S., & Gracia-Sancho, J. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0734 · Cited by 20
“…by these lipotoxic hepatocytes contain inhibitors of peroxisome proliferator activated receptor gamma ( PPARγ ), such as the miR128-3p, that can activate HSCs when internalized(104), and other miRNAs such as miR1297 and miR27a, all of them inducers of HSCs activation and proliferation(105,106).”
BackgroundHu, Z., Chen, G., Yan, C., Li, Z., Wu, T., Li, L., & Zhang, S. (2023) · Environmental Toxicology · doi:10.1002/tox.23795 · Cited by 18
Metadata
- Authors
- Luo, X., Xu, Z.-X., Wu, J.-C., Luo, S.-Z., & Xu, M.-Y.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 26
- Pages
- 1241-1254
- ISSN
- 2162-2531 (ISSN-L)
- OpenAlex
- W3211311865
- Cited by
- 64
- References
- 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatocyte-derived exosomal miR-27a activates hepatic stellate cells through the inhibition of PINK1-mediated mitophagy in MAFLD. https://app.cochat.ai/papers/10.1016/j.omtn.2021.10.022
- The paper
- Luo, X., Xu, Z.-X., Wu, J.-C., Luo, S.-Z., & Xu, M.-Y. (2021). Hepatocyte-derived exosomal miR-27a activates hepatic stellate cells through the inhibition of PINK1-mediated mitophagy in MAFLD. Molecular Therapy - Nucleic Acids. https://doi.org/10.1016/j.omtn.2021.10.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.